ANTITHROMBIN - ANVISA Registration 81457600023
Access comprehensive regulatory information for ANTITHROMBIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81457600023 and manufactured by TCOAG IRELAND LIMITED. The registration is held by STAGO BRASIL COMERCIO, IMPORTAÇÃO E EXPORTAÇÃO DE PRODUTOS DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, INSTRUMENTATION LABORATORY, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
81457600023
25351399782201992
22260124000220
Company Information
Dates and Status
Jun 15, 2020
VIGENTE
09/18/2025 19:00:01
ROCHE DIAGNOSTICS GMBH• Germany
INSTRUMENTATION LABORATORY• United States of America
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH• Germany
INSTRUMENTATION LABORATORY COMPANY• United States of America
INSTRUMENTATION LABORATORY CO.• United States of America
ANTITROMBINA
Família Precimat Chromogen e PreciChrom I/II
ROCHE DIAGNOSTICS GMBH
10287411628
Sep 22, 2022
ANTITROMBINA
AT (Antithrombin)_cobas c
ROCHE DIAGNOSTICS GMBH
10287411558
Jan 28, 2021
ANTITROMBINA
ANTITROMBINA III - BA400
BIOSYSTEMS S.A.
80367750064
Sep 14, 2020
ANTITROMBINA
Yumizen G AT
HORIBA ABX SAS
10347320330
Aug 24, 2020
ANTITROMBINA
Família Antithrombin
ROCHE DIAGNOSTICS GMBH
10287411356
Sep 10, 2018

